About Us
Overview
Management
News
Community
Sigma-Tau Group
Contact Us
Research
Overview
Pipeline
Products
Overview
Prescription Products
Consumer Products
Patient Support
Overview
PhRMA
Careers
Overview
Job Postings
Culture
Benefits
Overview
Health Benefits
Work-Life Benefits
Other Benefits
Compliance
Overview
Corporate Compliance Program
Declaration of Compliance
PhRMA Code on Interactions with Healthcare Professionals
04.29.13
Dave Lemus promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
05.01.13
Sigma-Tau Pharmaceuticals launches Cystaran
for the treatment of corneal cystine crystal accumulation in patients with cystinosis